Dosis Expands Kidney Care Platform With Iron Advisor Tool To Personalize Anemia Management

First Application of Its Kind Broadens Capabilities of Dosis’s Personalized Dosing Platform

SAN FRANCISCO–(BUSINESS WIRE)–Dosis, a market leader in artificial intelligence-powered precision dosing, today announced the expansion of its kidney care platform with the release of its Strategic Iron Advisor (SIA). It is being introduced as the first precision dosing tool on the market for intravenous iron.

SIA is a sub-module that works with Dosis’s existing anemia tool, Strategic Anemia Advisor (SAA), to personalize anemia management. SAA is widely used nationwide to personalize Erythropoiesis Stimulating Agents (ESA) dosing, and the SIA offering broadens the capabilities of Dosis’s personalized dosing platform.

“This release is a major step toward realizing Dosis’s goal of becoming the standard of care for chronic disease management,” said Shivrat Chhabra, co-founder and CEO at Dosis. “SIA demonstrates the extensibility of the Dosis platform.”

SIA issues dosing recommendations for IV iron, which is often dosed in tandem with ESAs to manage chronic anemia. Iron is an essential building block of red blood cells, and patients should be iron-replete in order for their chronic anemia to be managed as effectively and efficiently as possible.

Clinics that manage chronic anemia often have separate protocols for ESAs and IV iron, and they are typically burdensome to follow. Clinics that use SAA and SIA will be able to simultaneously access ESA and IV iron dose recommendations for their patients, easing the operational burden. By optimizing anemia management, clinics can reduce the utilization of both ESAs and IV iron, which reduces patient exposure to the drugs and the clinical cost of care. Clinics that use SAA are able to reduce their drug utilization by 25% on average, while maintaining or improving quality outcomes. Results with SIA are expected to be similar in magnitude.

“The release of SIA allows us to deepen our collaboration with our partner clinics and offer them a truly comprehensive solution for anemia management,” said Divya Chhabra, co-founder and COO at Dosis.

About Dosis

Dosis is a personalized dosing platform that was founded with the mission to transform chronic disease management by leveraging advancements in artificial intelligence and control algorithms. With a deep academic history, Dosis uses science, data, patient safety, and clinical evidence to inform decisions. For more information visit https://dosisinc.com.

Contacts

Miranda Honnoll

miranda@bospar.com
408-887-8486